Rg1 has been shown to improve neurological diseases through a variety of pharmacological effects, including apoptosis, miRNA, neuroinflammation, oxidative stress, the MAPK family, NF-κB, and learning and memory. The gene discussed is PPP1R3A; the disease is nervous system disorder.